Alamar Biosciences saw its market valuation reach $1.53 billion on Friday as its shares surged 33% during their Nasdaq debut. The company's stock opened at $22.60 per share, a significant climb from the initial offering price of $17.

The Nasdaq logo is pictured at the Nasdaq Market in New York City, New York, on February 27, 2026. REUTERS/Jeenah Moon/File Photo